Twelve of the 15 analysts surveyed by S&P Global (NYSE: SPGI) in April rated the pharmaceutical stock as a "buy" or "strong ...

Motor function improved with a favorable safety profile for patients with Parkinson’s disease who used tavapadon while receiving oral levodopa, according to a study published in JAMA Neurology.This ...

“Young-onset Parkinson’s disease, defined as diagnosis before the age of 50, accounts for approximately 5 to 10 per cent of ...

David Einhorn of Greenlight Capital manages a 13F portfolio that was worth more than $2.8 billion at the end of the fourth ...

Net Loss: The net loss attributable to Serina common stockholders for the year ended December 31, 2025 was $19.4 million, or $ (1.91) per basic and diluted share, compared to net loss of $11.1 million ...

Gut-targeted interventions are promising adjuncts to conventional Parkinson's therapy, improving patients' quality of life.

Parkinson’s, a neurodegenerative disorder once considered an illness of the elderly, is increasingly being diagnosed in younger adults.

Learn more about whether ACADIA Pharmaceuticals Inc. or Relay Therapeutics, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

In April 2026, XellSmart officially launches its multicenter Phase II registrational clinical trial of the Clinical-Grade, ...

Instead, her physician asked a question that stopped her cold: What about Parkinson’s disease? “What?” Suzanne remembers ...

Scientists comment on Bipolar Disorder following news about Kanye West. Prof David Curtis, Honorary Professor, UCL Genetics Institute, University College London (UCL), said: What is bipolar?

Shares of Soleno Therapeutics SLNO have surged 56.4% over the past week, driven primarily by the announcement that Neurocrine ...